Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Inventory Average (2020 - 2023)

Palatin Technologies' (PTN) quarterly Inventory Average came in at $1.1 million in Q3 2023, up 17.85% on a YoY basis from $901223.0 in Q3 2022, and up 83.75% quarter-over-quarter from $578016.5 in Q2 2023.

Analysis

Palatin Technologies (PTN) Inventory Average (2020 - 2023) Analysis & Trends

Palatin Technologies (PTN) has reported Inventory Average for 4 consecutive years, with $1.1 million the latest figure, recorded in Q3 2023.

  • For the quarter ending Q3 2023, Inventory Average rose 17.85% year-over-year to $1.1 million; the trailing twelve-month figure through Sep 2023 stood at $1.1 million (up 17.85% YoY), and the FY2023 full-year result was $735235.5, down 30.19% from the prior year.
  • Inventory Average rose to $1.1 million in Q3 2023 per PTN's latest filing, from $578016.5 in the prior quarter.
  • Across five years, Inventory Average topped out at $6.1 million in Q1 2021 and bottomed at $578016.5 in Q2 2023.
  • Historically, Inventory Average has averaged $2.0 million across 4 years, with a median of $1.1 million in 2022.
  • The sharpest annual moves came in 2022 and 2023: Inventory Average plunged 82.62% in 2022, then increased 17.85% in 2023.
  • Over 4 years, Inventory Average stood at $5.9 million in 2020, then tumbled by 81.5% to $1.1 million in 2021, then retreated by 26.05% to $808621.5 in 2022, then jumped by 31.35% to $1.1 million in 2023.
  • According to Business Quant data, Inventory Average over the past three periods registered $1.1 million, $578016.5, and $694650.5 for Q3 2023, Q2 2023, and Q1 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 6.20 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 1.93 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 1.77 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 3.09 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 213.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 90.57 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 2.17 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Palatin Technologies 46.98 Mn 46.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 1.06 Mn
Jun 30, 2023 578,016.50
Mar 31, 2023 694,650.50
Dec 31, 2022 808,621.50
Sep 30, 2022 901,223.00
Jun 30, 2022 988,229.50
Mar 31, 2022 1.06 Mn
Dec 31, 2021 1.09 Mn
Sep 30, 2021 1.14 Mn
Jun 30, 2021 3.64 Mn
Mar 31, 2021 6.07 Mn
Dec 31, 2020 5.91 Mn